Intermittent Fasting Fails to Match Hype
A major review found that intermittent fasting "fails to match the hype," making little to no difference in weight loss or quality of life compared to other eating patterns. The Cochrane review suggests intermittent fasting is not harmful but may make little difference to weight loss outcomes. While not a magic solution, the evidence indicates it's not superior to other dietary approaches for most people.
- The comprehensive Cochrane review synthesized data from 22 different randomized clinical trials that included a total of 1,995 adults with overweight or obesity from North America, Europe, China, Australia, and South America. - The analysis covered several popular methods of intermittent fasting, including alternate-day fasting, periodic fasting like the 5:2 diet, and time-restricted eating, where food intake is limited to a specific window each day. - When compared to taking no dietary advice, intermittent fasting resulted in an average weight loss of only about 3% of a person's body weight, which is below the 5% threshold that doctors generally consider to be clinically meaningful. - Dr. Luis Garegnani, the review's lead author, stated that the current evidence doesn't justify the enthusiasm seen on social media, concluding that while it's not worse than other diets, it doesn't appear to be clearly better. - Researchers noted significant limitations in the available evidence, pointing out that most studies were short-term, following participants for a maximum of 12 months, and that none of the 22 trials reported on participants' satisfaction with the fasting regimens. - The review found little to no difference in quality of life outcomes between intermittent fasting and traditional dietary advice. - Potential side effects of intermittent fasting, such as fatigue, headaches, or nausea, were inconsistently reported across the studies, making it difficult for the reviewers to draw firm conclusions about the diet's harms.
